REQUEST A DEMO
Total
USD $0.00
Search more companies

Ginsberg Ecuador S.A. (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Ginsberg Ecuador S.A. Profile Updated: June 27, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Ginsberg Ecuador S.A. is an enterprise based in Ecuador. Its main office is in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was first established on April 17, 2006. There are currently 3,178 (2017) people employed by Ginsberg Ecuador S.A.. In 2023, the company reported a net sales revenue drop of 87.61%. During that time, Ginsberg Ecuador S.A.’s total assets decreased by 2.91%. In, 2023, the company’s net profit margin decreased by 85.14%.

Headquarters
Antonio Castillo N76-119 , Floor 240
Quito; Pichincha;

Contact Details: Purchase the Ginsberg Ecuador S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Ginsberg Ecuador S.A. report to view the information.
Outstanding Shares:
Purchase the Ginsberg Ecuador S.A. report to view the information.
Registered Capital:
Purchase the Ginsberg Ecuador S.A. report to view the information.
Incorporation Date:
April 17, 2006
Key Executives
Purchase this report to view the information.
Liquidator
Ownership Details
Purchase this report to view the information.
99.22%
Purchase this report to view the information.
0.41%
Purchase this report to view the information.
0.37%
Subsidiaries
Hospital Vozandes del Ecuador S.A.
88%
Company Performance
Financial values in the chart are available after Ginsberg Ecuador S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-87.61%
Total operating revenue
-87.61%
Operating profit (EBIT)
N/A
EBITDA
-85.3%
Net Profit (Loss) for the Period
-109.27%
Total assets
-2.91%
Total equity
-6.77%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
-85.14%
Return on Equity (ROE)
-4.03%
Debt to Equity Ratio
13.62%
Quick Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?